Rice Hall James & Associates LLC Has $1.99 Million Position in Azenta, Inc. (NASDAQ:AZTA)

Rice Hall James & Associates LLC cut its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 1.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 40,971 shares of the company’s stock after selling 437 shares during the quarter. Rice Hall James & Associates LLC owned approximately 0.08% of Azenta worth $1,985,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in Azenta by 1.9% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after buying an additional 100,826 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Azenta by 16.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after buying an additional 421,719 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in Azenta by 16.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock worth $62,917,000 after buying an additional 183,040 shares during the period. Bank of New York Mellon Corp lifted its holdings in Azenta by 3.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 515,393 shares of the company’s stock worth $27,120,000 after buying an additional 18,680 shares during the period. Finally, Federated Hermes Inc. lifted its stake in shares of Azenta by 6.3% in the 2nd quarter. Federated Hermes Inc. now owns 432,506 shares of the company’s stock valued at $22,758,000 after purchasing an additional 25,586 shares during the period. 99.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AZTA has been the topic of a number of recent analyst reports. Evercore ISI dropped their price objective on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Needham & Company LLC reissued a “buy” rating and issued a $69.00 price objective on shares of Azenta in a research note on Wednesday, August 7th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Azenta has an average rating of “Hold” and a consensus price target of $66.40.

Azenta Price Performance

Shares of Azenta stock opened at $41.22 on Friday. Azenta, Inc. has a one year low of $40.24 and a one year high of $69.16. The firm has a market capitalization of $2.02 billion, a price-to-earnings ratio of -14.67 and a beta of 1.47. The business has a 50-day simple moving average of $46.31 and a 200 day simple moving average of $50.93.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.09. The firm had revenue of $173.00 million during the quarter, compared to analyst estimates of $166.14 million. Azenta had a positive return on equity of 0.89% and a negative net margin of 23.66%. The company’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.13 EPS. On average, sell-side analysts expect that Azenta, Inc. will post 0.33 EPS for the current year.

Insiders Place Their Bets

In other Azenta news, CFO Herman Cueto sold 1,595 shares of the business’s stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the sale, the chief financial officer now directly owns 24,604 shares of the company’s stock, valued at approximately $1,074,702.72. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.77% of the company’s stock.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.